-
The COVID-19 pandemic poses major challenges to doctors and health systems worldwide. People with pre-existing health conditions have an even higher risk of experiencing a severe infection. Publications in medical journals and by independent organizations indicate that the exact measurement of vital parameters can play a major role in the treatment of risk groups with COVID-19. Height, weight, and vital signs such as blood pressure, oxygen saturation, pulse, and temperature are relevant for the exact dosage of medications and ventilator settings. In addition, this information helps with disease diagnosis and follow-up control measures.
Supply of hospitals, emergency departments and medical practices has the highest priority
-
In many countries, authorities and competent institutions have classified seca and its medical technology as system relevant to support health systems in the fight against the COVID 19 pandemic. Due to the current situation, the pressure in emergency rooms and hospitals is very high and the need for medical technology has continued to increase. The company is maintaining production and expanding capacities to best serve this demand and to contribute to the fight against the corona virus.
-
While the whole world is attempting to slow down the number of new infections with coronavirus, we are concentrating on protecting our employees and instituting measures to make sure our production in Hamburg remains fully operational. Our production site in Hangzhou has returned to 90 percent of production capacity since China ended its shutdown. That gives us hope and sends a positive signal to everyone. We take this opportunity to thank all our employees and partners whose support and engagement are keeping our products and service available to all who need them.
EU Medical Device Regulation successfully implemented three months before it fully comes into force
-
As one of the first Med Tech companies in Europe, seca is the global market leader in medical measuring and weighing and has passed the official MDR (Medical Device Regulation) audit even before the new EU regulation comes into effect in May 2020. Three auditors from the Notified Body (TÜV-SÜD Product Service) analyzed and audited the seca quality management system in accordance with the MDR requirements for medical devices and assessed all of them as successfully met.
Validated BIA from seca conforms to consensus on diagnostic methods
-
The international societies ASPEN, ESPEN, FELANPE and PENSA established the Global Leadership Initiative in Malnutrition (GLIM) to build a worldwide consensus for diagnostic criteria for malnutrition. The consensus report published in September 2018 elevates reduced muscle mass to one of the decisive, independent evaluation criteria used in the diagnosis of malnutrition. seca welcomes this step, which the company sees as validation of its advocacy of improved diagnosis and treatment of malnutrition.
German medical technology company to build on successful projects in viable Benelux markets
-
Right on the heels of the November opening of the seca | lietuva site, the market leader in medical measuring systems and scales has opened its 16th international subsidiary seca | benelux. The company sees great potential in the progressive healthcare sector in Benelux countries and opportunities for sales, particularly of its EMR-ready and digital measuring solutions.
-
seca, the global market leader in medical measuring systems and scales, is opening its 15th branch in the Lithuanian capital of Vilnius. With the establishment of the first site dedicated to development only, seca is driving forward its digital transformation from a scale manufacturer to a software and system provider. seca will first hire 10 IT specialists to develop a new software solution that will take seca into new medical business fields. The team is expected to grow to 25 employees by 2021.
Quality management satisfies global requirements and secures seca competitive advantages
-
The German and French quality management systems of seca, the leading manufacturer of medical measuring systems and scales, have been certified according to the revised standards ISO 9001 and ISO 13485 in an audit conducted by TÜV-Süd. In addition, the quality management system at seca headquarters in Hamburg received the Medical Device Single Audit Program (MDSAP) certificate. It shows that seca officially satisfies not only the legal requirements in Europe, but also in the USA, Canada, Australia, Japan and Brazil.
